Hospital Acquired Infections Testing Kits Market Growth In 2026: Market Size, Key Drivers And Future Outlook
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Hospital Acquired Infections Testing Kits Market Poised To Hit $7.2 Billion By 2030 With A 8.5% CAGR
The market size for hospital acquired infections testing kits has shown strong expansion in recent years. It is projected to increase from $4.79 billion in 2025 to $5.19 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.5%. The expansion witnessed in the past can be credited to factors like the rise in hospital infection surveillance, the growing occurrence of antibiotic-resistant pathogens, the expansion of clinical microbiology laboratories, the execution of infection control protocols, and the accessibility of molecular diagnostic tools.
The market for hospital acquired infections testing kits is expected to demonstrate significant expansion in the coming years. This sector is projected to reach $7.2 billion in 2030, achieving a compound annual growth rate (CAGR) of 8.5%. The projected growth during this period can be attributed to a heightened focus on early infection detection, increased investments in hospital safety infrastructure, the expanding adoption of rapid testing, a growing demand for automated diagnostic workflows, and advancements in molecular diagnostics technology. Prominent trends expected in the forecast period include the increasing uptake of rapid diagnostic test kits, a rise in the use of molecular testing for HAIs, the growing integration of automated diagnostic instruments, the expansion of point-of-care infection testing, and an enhanced emphasis on multi-pathogen detection.
Get A Free Sample Report With In-Depth Market Insights:
Hospital Acquired Infections Testing Kits Market Growth Catalysts And Demand Drivers
The expansion in healthcare settings is projected to boost the hospital-acquired infections testing kits market going forward. Within these settings, a broad spectrum of facilities exists, such as acute care hospitals, urgent care centers, rehabilitation centers, nursing homes, and long-term care facilities, providing diverse healthcare services. Crucially, hospital-acquired infections testing kits serve as essential instruments for identifying and averting nosocomial infections, thereby improving patient safety within medical establishments. As an illustration, data from the American Hospital Association, a US-based healthcare industry trade group, indicated a substantial rise in the total number of hospitals across the U.S. region from 6,093 in 2022 to 60,129 in 2023, as of May 2023. Furthermore, community hospital admissions grew from 31,393,318 in 2022 to 31,967,073 in 2023. Consequently, the increasing prevalence of healthcare settings fuels the hospital-acquired infections testing kits market.
Hospital Acquired Infections Testing Kits Market Segments: Where Is Growth Concentrated?
The hospital acquired infections testing kits market covered in this report is segmented –
1) By Product: Consumables And Reagents, Instruments
2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others
3) By Pathogen Type: Viral, Bacterial, Fungal
4) By Application: Drug Resistance Testing, Disease Testing
Subsegments:
1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)
2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)
Hospital Acquired Infections Testing Kits Market Trends Shaping Long-Term Demand
Leading companies active in the hospital-acquired infections (HAI) testing kits market are prioritizing the development of advanced point-of-care antimicrobial susceptibility testing (AST) solutions. This focus aims to enable rapid diagnosis, guide specific therapies, and combat antimicrobial resistance (AMR). Point-of-care AST employs proprietary microfluidic technology to swiftly identify bacterial presence and evaluate antibiotic effectiveness directly from patient urine samples, thereby reducing diagnostic delays and improving treatment decisions. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, introduced the world’s first point-of-care testing system in Europe designed to perform antimicrobial susceptibility testing in just 30 minutes. By utilizing a microfluidic-based AST approach for patients with suspected urinary tract infections, the system significantly cuts down turnaround time and supports antimicrobial stewardship in primary care settings through enabling timely and informed antibiotic use, consequently contributing to global efforts to curb AMR.
Hospital Acquired Infections Testing Kits Market Leading Companies And Competitive Benchmarking
Major companies operating in the hospital acquired infections testing kits market are Becton Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, GE Healthcare, Seegene, SD Biosensor, Fujirebio, Sysmex Corporation, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, ImmunoScience, Vivacheck Lab
View The Full Hospital Acquired Infections Testing Kits Market Report:
Hospital Acquired Infections Testing Kits Market Top Region By Revenue And Market Share
North America was the largest region in the hospital-acquired infections testing kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
